Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sarcoma × Radiotherapy × Clear all

Status

Sponsor Class

Study Type

Interventional 64 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 20 Head and Neck Neoplasms 15 Prostatic Neoplasms 12 Neoplasms 12 Lung Neoplasms 11 Radiation Injuries 8 Esophageal Neoplasms 8 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Glioblastoma 5 Neoplasm Metastasis 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Central Nervous System Neoplasms 3 Astrocytoma 3 Xerostomia 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Pelvic Neoplasms 2 Osteoradionecrosis 2 Esthesioneuroblastoma, Olfactory 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Adenocarcinoma 2 Vulvar Neoplasms 1

Interventions

Gene Expression Profiling 8 Surveys and Questionnaires 5 Polymerase Chain Reaction 5 Blood Specimen Collection 5 Surgical Procedures, Operative 4 Microarray Analysis 4 Immunohistochemistry 4 Base Sequence 4 Trabectedin 3 Therapeutics 3 Reverse Transcriptase Polymerase Chain Reaction 3 Observation 3 Radiation 2 Psychiatric Rehabilitation 2 In Situ Hybridization, Fluorescence 2 Gene Rearrangement 2 Drug Therapy 2 DNA Methylation 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 pazopanib 1 liposomal doxorubicin 1 eribulin 1 Watchful Waiting 1 Ropivacaine 1 Referral and Consultation 1 Radiotherapy 1 Radionuclide Imaging 1 Radiation, Ionizing 1 Quality Assurance, Health Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978039 2025-09-04

BCB-Sarcomes

Institut Bergonié

150,000 enrolled

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡